Literature DB >> 4009285

Pancreas accumulation of radioiodinated HIPDM in mice and rats.

K Yamamoto, P Som, S C Srivastava, G E Meinken, A B Brill.   

Abstract

High pancreatic affinity for 131I-labeled HIPDM was observed in mice and rats. Although the brain uptake of [131I]HIPDM is very fast, the pancreatic uptake is rather slow. The pancreas to liver ratios (per gram) were 5.08 +/- 0.52 in mice and 5.15 +/- 0.65 in rats at 2 hr and 7.05 +/- 0.53 in mice and 8.06 +/- 1.14 in rats at 5 hr after administration. These ratios are higher than those obtained with routinely used pancreatic agent [75Se]selenomethionine. An increase in liver uptake and decrease in pancreatic uptake was observed at higher dose of carrier HIPDM, which resulted in lower pancreas to liver ratios. HIPDM is a new type of compound which shows predilection for pancreas. Our results suggest that [123I]HIPDM might be a useful agent for pancreas imaging.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009285

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability.

Authors:  Pei-Wen Li; Shi Luo; Lin-Yu Xiao; Bo-le Tian; Li Wang; Zhi-Rong Zhang; Ying-Chun Zeng
Journal:  Acta Pharmacol Sin       Date:  2019-04-23       Impact factor: 6.150

2.  Accumulation and metabolism of [125I]HIPDM in the rat pancreas.

Authors:  H Saji; Y Kuge; D Tsutsumi; K Yamamoto; J Konishi; A Yokoyama
Journal:  Ann Nucl Med       Date:  1991-11       Impact factor: 2.668

3.  Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer.

Authors:  Yang Chen; Li Wang; Shi Luo; Jun Hu; Xing Huang; Pei-Wen Li; Yi Zhang; Chao Wu; Bo-Le Tian
Journal:  Drug Des Devel Ther       Date:  2020-07-23       Impact factor: 4.162

4.  Drug discovery and formulation development for acute pancreatitis.

Authors:  Xue Jiang; Ya-Wen Zheng; Shihui Bao; Hailin Zhang; Ruijie Chen; Qing Yao; Longfa Kou
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.